Delivery Order SPE2DB22D9311-SPE2DB24FP6XT

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,815.90 firm fixed-price contract is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a pharmaceutical product, with a period of performance ending on January 17, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,807.60 firm fixed-price contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract, valued at $2,062.24, is for the delivery of Boostrix TDAP vaccine syringes. The award has no set-aside designation and is part of a larger $4,999,999 indefinite delivery vehicle (IDV) that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical items...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,195,547 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a ceiling value of $4,782.78. The contract is a firm fixed-price delivery order with an ultimate completion date of October 23, 2024. DMS Pharmaceutical Group Inc. holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a $3,145.80 firm fixed-price delivery order for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a specialized pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and was awarded on January 21, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the BOOSTRIX TDAP VACCINE VIAL 0.5ML. This order, valued at $2,790.70, is part of a larger indefinite delivery contract that DMS Pharmaceutical Group holds with the Defense Logistics Agency to supply a variety of pharmaceutical items and medical supplies, including medications, vaccines, and other products, to support military...
This is a delivery order under a $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, and the U.S. Defense Logistics Agency (DLA). The order is for BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $14,067.00 and a firm fixed price. The contract has no set-aside designation. DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,880.40 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to fulfill the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The $33,760.80 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which provides a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $28,076.00, is a firm fixed-price delivery order for BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The award is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
  • SPE2DB22D9311
    Indefinite Delivery Contract
  • SPE2DB22D9311-SPE2DB24FP6XT
    Delivery Order

This is a $28,696.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the BOOSTRIX TDAP vaccine syringe, 0.5 mL, with a completion date of June 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. This delivery order is not associated with any set-aside designation.

Generated 9/12/24, 11:00 AM